SEA BASS & SEA BREAM
Advanced diagnostic approaches for fish disease are welcome, but sometimes simpler is better
With technologies for molecular diagnosis of fish disease increasingly available, sometimes simpler approaches that have great diagnostic power are being ignored.
Safety and welfare concerns drive shift to licensed anesthetic in Mediterranean aquaculture
Improving standards on Mediterranean fish farms is driving interest in Tricaine PHARMAQ — the only authorized fish anesthetic product.
Vaccines boost Greece’s seabass and seabream aquaculture — but challenges remain
Aquaculture in Greece has endured some ups and downs since its establishment in the 1980s, from the Greek financial crisis to the Covid-19 pandemic.
Producing healthy barramundi — one of sustainable aquaculture’s great hopes
Barramundi has much potential as a sustainable fish in the marine tropics — but health challenges remain for producers. Josh Goldman, CEO of Australis, explains his company’s approach.
Eastern Mediterranean sea bass more resistant to highly pathogenic virus strain
Eastern Mediterranean populations of sea bass showed three times the survival rate of Atlantic Ocean and Western Mediterranean stocks against a pathogenic strain of nervous necrosis virus (NNV) in a new challenge study.
Vaccine ‘work in progress’ in major aquaculture markets, Part 1: Sea bass
European sea bass aquaculture is centered on the Mediterranean basin, and there are a number of notable pathogens which can cause high mortality on production sites through direct and indirect effects.
Why fish vaccines are increasingly coming in smaller doses
An interview with Dr Bjørn Brudeseth, PhD, PHARMAQ
Pathologies in Mediterranean finfish: Causes and control strategies
By Valerio Vitalini, MSc
Aquaculture consultant, Rome, Italy
- « Previous
- 1
- 2
